Tempest Therapeutics, Inc. (TPST)
Nasdaq: TPST · Pharmaceutical Preparations · Brisbane, CA · filing with the SEC since 2012
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Report filed | Mar 30, 2026 | Mar 27, 2025 | Mar 19, 2024 | Mar 22, 2023 | Mar 29, 2022 | Mar 29, 2021 | Mar 11, 2020 | Apr 1, 2019 | Mar 15, 2018 | Mar 2, 2017 |
| Revenue | · | · | · | · | · | · | · | · | 295 | 653 |
| Cost of revenue | · | · | · | · | · | · | · | · | 790 | 5,401 |
| Research and development | 12,606 | 28,476 | 17,498 | 22,527 | 17,166 | 14,389r | 27,843 | 14,425 | 14,526 | 21,641 |
| Selling, general and administrative | · | · | · | · | · | · | · | · | 27,744 | 49,223 |
| General and administrative | 13,969 | 13,550 | 11,659 | 12,113 | 9,820 | 4,909r | 17,556 | 8,691 | 5,956 | · |
| Total operating expenses | · | · | · | · | · | · | · | · | 50,901 | 81,665 |
| Operating income | -26,575 | -42,026 | -29,157 | -34,640 | -26,986 | -19,298r | -45,399 | -26,874 | -84,326r | -81,012 |
| Interest expense | 207 | 1,316 | 1,449 | 1,618 | 1,282 | 0 | · | 134 | 288 | · |
| Interest and investment income | · | · | · | · | · | · | · | · | 752 | 659 |
| Interest income (expense), net | · | · | · | · | · | 155 | 1,038 | -134 | · | · |
| Share of profit of equity-method investments | · | · | · | · | · | · | · | · | -1,018 | -1,542 |
| Other income (expense), net | 520 | 1,499 | 1,115 | 549 | -34 | 90 | · | · | -36 | -164 |
| Total non-operating income (expense) | 313 | 183 | -334 | -1,069 | -1,316 | 90 | · | · | · | · |
| Income before income taxes | · | · | · | · | · | · | · | · | -50,908 | -82,059 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | · | · | 67 | 201 |
| Net income including non-controlling interests | -26,262 | -41,843 | -29,491 | -35,709 | -28,302 | -19,208r | -44,568 | -27,177 | -84,586 | · |
| Net income to non-controlling interests | · | · | · | · | · | · | 0 | 15 | -8 | · |
| Net income | -26,262 | -41,843 | -29,491 | -35,709 | -28,302 | -19,208r | -44,568 | -27,192 | -84,578r | -82,260 |
| Net income to common shareholders | · | · | · | · | · | · | · | · | -50,975 | -82,260 |
| Earnings per share, basic | -6.33 | -19.50r | -24.83b | -40.17b | -97.11b | -533.39b | · | · | · | · |
| Earnings per share, diluted | -6.33 | -19.50r | -24.83b | -40.17b | -97.11b | -533.39b | · | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | · | -25.09b | -42.25b | -228.54b | -4,183.53rb | -33.28b |
| Weighted average shares, basic | 4,149,733 | 2,146,276r | 1,185,862b | 888,377b | 291,562b | 36,012b | · | · | · | · |
| Weighted average shares, diluted | 4,149,733 | 2,146,276r | 1,185,862b | 888,377b | 291,562b | 36,012b | · | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | · | 1,450,964b | 1,054,365b | 119,004b | 20,217rb | 2,472,923b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-13 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeNetInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetShare of profit of equity-method investments its share of companies it partly owns
us-gaap:IncomeLossFromEquityMethodInvestmentsOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted